Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures

NCT06495749 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT06495749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06495749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures
Lead sponsor
Zhejiang University
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2024
Completion date
December 31, 2027
Enrollment
3,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer resectable